-
SAN ANTONIO -- Bristol-Myers Squibb Company today announced new data from studies of IXEMPRA(TM) (ixabepilone) plus capecitabine compared to capectabine alone, including a pre-specified sub set analysis demonstrating a significant increase in progression free survival (PFS) in patients with triple negative breast cancer. The study results - which are from ...
-
HUNTINGTON BEACH, California and AMSTERDAM -- Agendia, a world leader in molecular cancer diagnostics, today announced MammaPrint(R)'s ability to predict response to neoadjuvant chemotherapy in breast cancer. Dr. Laura van 't Veer, from the Netherlands Cancer Institute, presented the data at the 2008 San Antonio Breast Cancer Symposium (SABCS) during ...
-
COLLEGEVILLE, Pa. -- Wyeth Pharmaceuticals, a division of Wyeth, today announced data from an open-label phase 2 clinical trial of neratinib (HKI-272) in women with advanced HER-2-positive breast cancer. These data suggest that neratinib has antitumor activity in patients with advanced breast cancer positive for the ErbB-2 receptor (also known ...
-
BOSTON -- The DNA Repair Company (DNAR), an early-stage company focused on personalized approaches to cancer treatment, announced today that it has identified a promising set of protein biomarkers that may aid in the treatment of a particularly aggressive form of breast cancer. These findings were presented at the CTRC-AACR ...
-
Estrogen is medicine's most two-faced hormone, confusing doctors and patients for decades on its role in the benefits and risks of heart disease and cancer. Now researchers at Washington University have shown that in some women with breast cancer tumors that thrive on the hormone, giving them more estrogen actually ...
-
FRIMLEY, England -- Adding Zometa to Chemotherapy Prior to Surgery Led to an Additional 33% Reduction in Tumour Size, Resulting in Fewer Mastectomies New Data is First to Demonstrate Direct Effect of Zometa to Help Shrink Primary Tumours; Further Evidence of Zometa as a Potential Anticancer Therapy New data released ...
-
The Patient Advocate Foundation (PAF), with support from ImpediMed Ltd. , is pleased to announce the launch of the Lymphedema CareLine (LCL). PAF, through its MedCare Division, is offering the national, toll-free patient/provider hotline designed to provide information and assistance to breast cancer patients who are or may be at ...
-
Latina women who prefer speaking Spanish are more likely than other ethnic groups to express regret or dissatisfaction with their breast cancer treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center. Despite receiving similar treatment, Latina women were 5.6 times more likely than ...
-
Breast-Specific Gamma Imaging (BSGI) is shown to be an effective method of identifying mammographically and clinically occult (hidden) breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. According to findings presented today at the annual meeting ...
-
A stunning discovery based on epigenetics (the inheritance of propensities acquired in the womb) reveals that consuming choline a nutrient found in eggs and other foods during pregnancy may significantly affect breast cancer outcomes for a mother's offspring. This finding by a team of biologists at Boston University is the ...
-
A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. Results will be presented today at the annual ...
-
Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. In addition, a misclassification of ...
-
Researchers have developed a new type of imaging compound that allows them to visualize viable breast cancer cells that have spread to the lungs in mice. The compound binds to a protein called HER2, which is found on the surface of some breast cancer cells, and it glows, or fluoresces, ...
-
CHICAGO -- Early clinical experience with the FDA cleared Visica 2(TM) Treatment System from Sanarus Medical confirms the effectiveness of ultrasound guided cryoablation to completely eradicate small, unifocal Invasive Ductal Breast Cancer (IDC). Initial data from this multi-center study was presented at the 94th Scientific Assembly and Annual Meeting of ...
-
WASHINGTON -- Breast-specific gamma imaging (BSGI) is effective in detecting cancers unfound on mammograms or by clinical exam, according to a study published Thursday at an annual academic meeting. "BSGI can identify the most difficult to detect breast cancer -- invasive lobular carcinoma," said lead author Rachel Brem from George ...
-
NEWPORT NEWS, Va., and SAN DIEGO -- The Patient Advocate Foundation (PAF), with support from ImpediMed Ltd., is pleased to announce the launch of the Lymphedema CareLine (LCL). PAF, through its MedCare Division, is offering the national, toll-free patient/provider hotline designed to provide information and assistance to breast cancer patients ...
-
CHICAGO -- A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. Results will be presented today at ...
-
CHICAGO -- Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Patients treated with brachytherapy have better cosmetic outcomes and ...
-
Scientists at the University of Texas at Austin have identified pathways by which a reduced-calorie diet and exercise can modify a postmenopausal woman's risk of breast cancer. The results, presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, suggest that both ...
-
If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research from the University of North Carolina at Chapel Hill School of Medicine takes a step in that direction. Carol Otey, Ph.D. and UNC colleagues ...
